DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Exelixis, Inc. (EXEL)
« Back to company indexEXEL Chatter Timeline
Stock Ticker for EXEL
Most Active Tweeters for EXEL
| User | Tweets |
|---|---|
| @StockTexts | 9 |
| @confcalltran | 4 |
| @AmericanBanking | 3 |
| @wuzupwidat | 3 |
| @1MinuteStock | 2 |
Recent Tweets for EXEL
 |
@prosperousguy @semodough $EXEL ? Wondering if the potential BO hype is real 6:09am |
 |
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/OYrHvPhjU0 5:09am |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/Blx4KwBYbP September 15th 2019, 9:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/O85J1ELkaU September 15th 2019, 7:09pm |
 |
@AmericanBanking Exelixis, Inc. $EXEL Short Interest Up 7.1% in August https://t.co/Dh0jOYvyjx #stocks September 15th 2019, 7:09pm |
 |
@WatchlistN Exelixis, Inc. $EXEL Short Interest Up 7.1% in August https://t.co/PSxSjNAxMH September 15th 2019, 7:09pm |
 |
@dailypoliticaln Exelixis, Inc. $EXEL Short Interest Up 7.1% in August https://t.co/An9PSmJKcx September 15th 2019, 7:09pm |
 |
@ZolmaxNews Exelixis, Inc. $EXEL Short Interest Up 7.1% in August https://t.co/LOPIPEa9hH September 15th 2019, 7:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/G1KbD8Vs5Y September 15th 2019, 6:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/O85J1F2V2s September 15th 2019, 5:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/kikobStEFE September 15th 2019, 4:09pm |
|
@AmericanBanking Exelixis, Inc. $EXEL Given Consensus Rating of “Hold” by Brokerages https://t.co/Bspc6o96DM #stocks September 15th 2019, 9:09am |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/kikobSc3h4 September 15th 2019, 8:09am |
 |
@IRAMarketReport Patrick J. Haley Sells 1,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/0mRva4Ixd4 #markets September 14th 2019, 7:09pm |
 |
@chaffeybreeze Patrick J. Haley Sells 1,000 Shares of Exelixis, Inc. $EXEL Stock https://t.co/ngR2Ev9iAv #stocks September 14th 2019, 7:09pm |
 |
@ConsumerFeed Insider Selling: Exelixis, Inc. $EXEL VP Sells 1,000 Shares of Stock https://t.co/jcPrlSNYVJ September 14th 2019, 7:09pm |
 |
@dakotafinancial Head to Head Analysis: Exelixis $EXEL & National Research $NRC https://t.co/avrV7X7c6b September 14th 2019, 2:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/Blx4KwTz3n September 14th 2019, 2:09pm |
 |
@1MinuteStock Recommendation #HOLD for $EXEL with UB rating - 2.54 out of 5. https://t.co/ODZDm2s3Zz September 13th 2019, 11:09pm |
 |
@InsiderAlertsIA $EXEL: New Insider Filing on Pres, Prod Dev & Med Aff & CMO GISELA SCHWAB: https://t.co/dkGzQQtbBC September 13th 2019, 9:09pm |
 |
@confcalltran Sr. Vice President of Exelixis just picked up 4,059 shares https://t.co/fElSfX0PnV $EXEL September 13th 2019, 8:09pm |
|
@confcalltran Exelixis's EVP and CFO just picked up 7,658 shares https://t.co/dBjP6PPUkI $EXEL September 13th 2019, 8:09pm |
|
@StockTexts $EXEL Exelixis, Inc. SEC Filing: Form 4 https://t.co/FTnUVA8cHu September 13th 2019, 8:09pm |
|
@confcalltran Pres of Exelixis just picked up 7,818 shares https://t.co/1xyksgMVqg $EXEL September 13th 2019, 8:09pm |
|
@1MinuteStock Btw, Estimated #Earnings Per Share for $EXEL is $0.09 it's 0.47% of the current price https://t.co/x29DFHClTt September 13th 2019, 10:09am |
 |
@wuzupwidat @josh_gagliardi @petenajarian What did he say ? $EXEL September 13th 2019, 6:09am |
|
@wuzupwidat 26k loaded on 8/30 I haven't forgotten you $EXEL $22 10/30 calls Time to start buying ahead of that October surp… https://t.co/1dTksm30U0 September 13th 2019, 6:09am |
 |
@sergiosergini @hammertrades18 Check also $exel, not exactly the same but quiet interesting September 13th 2019, 2:09am |
|
@InsiderAlertsIA $EXEL: New Insider Filing on Sr. Vice President, Commercial PATRICK J. HALEY: https://t.co/hwruPkpIlg September 12th 2019, 9:09pm |
|
@dailypoliticaln Exelixis, Inc. $EXEL VP Patrick J. Haley Sells 1,000 Shares https://t.co/B4HvbNelPw September 12th 2019, 9:09pm |
|
@AmericanBanking Insider Selling: Exelixis, Inc. $EXEL VP Sells 1,000 Shares of Stock https://t.co/SfxqyQPwEQ #stocks September 12th 2019, 9:09pm |
|
@ZolmaxNews Insider Selling: Exelixis, Inc. $EXEL VP Sells 1,000 Shares of Stock https://t.co/KA328lACdK September 12th 2019, 9:09pm |
|
@WatchlistN Insider Selling: Exelixis, Inc. $EXEL VP Sells 1,000 Shares of Stock https://t.co/zephkA1h8v September 12th 2019, 9:09pm |
 |
@insiderbuyings $EXEL new insider selling: 1000 shares. https://t.co/xjRrt9auMW September 12th 2019, 9:09pm |
|
@confcalltran Sr. Vice President of Exelixis just disposed of 1,000 shares https://t.co/CmSyax46J9 $EXEL September 12th 2019, 8:09pm |
|
@wuzupwidat $EXEL 10/20 calls... you know how we do ! September 12th 2019, 2:09pm |
 |
@josh_gagliardi @petenajarian just curious if you’re still in those $EXEL 22 Oct calls? September 12th 2019, 12:09pm |
 |
@Gambiste1 RT @Everlynpdram: $EXEL stated tonight during their healthcare conference that they are seeing a nice uptick in scripts. Sounded very bull… September 10th 2019, 9:09pm |
 |
@Everlynpdram $EXEL stated tonight during their healthcare conference that they are seeing a nice uptick in scripts. Sounded very bullish. September 10th 2019, 8:09pm |
 |
@slick_trader24 $EXEL flush and rebound September 10th 2019, 1:09pm |
 |
@ExelixisInc Investors: $EXEL to present at the @MorganStanley Global Healthcare Conference today at 4:40 PM ET. Details:… https://t.co/RMuk3vwiJI September 10th 2019, 12:09pm |
 |
@Moonshot_071669 @biogemfinder $EXEL Source for the $50 #buyout price? September 9th 2019, 3:09pm |
 |
@BonanzaBiotech Bought back 2500 $EXEL at $18.90 September 9th 2019, 3:09pm |
 |
@MC_OptionTrades $EXEL 20-Sep-19 Straddle Implies a ±6.8% move. Sep 10 Morgan Stanley 17th Annual Global Healthcare Conference https://t.co/e43kZM5pj3 September 9th 2019, 9:09am |
 |
@prosperousguy @BioRunUp Anything on $EXEL? TIA August 11th 2019, 7:08pm |
 |
@RolandoAMoreno RT @semodough: catalysts $EXEL: (1) 2H19: Phase 1b data from Cabometyx + Tecentriq from multiple tumors (COSMIC-021), (2) 2H19: Phase 2 dat… August 11th 2019, 8:08am |
|
@AmericanBanking Exelixis, Inc. $EXEL Expected to Announce Quarterly Sales of $226.04 Million https://t.co/u2zgtLgdzF #stocks August 11th 2019, 7:08am |
 |
@semodough catalysts $EXEL: (1) 2H19: Phase 1b data from Cabometyx + Tecentriq from multiple tumors (COSMIC-021), (2) 2H19: Ph… https://t.co/ug1FYZbqMm August 10th 2019, 5:08pm |
 |
@registrarjourn Exelixis $EXEL Upgraded at Zacks Investment Research https://t.co/h9Ub72aW05 August 10th 2019, 2:08pm |
 |
@EnterpriseLeade Exelixis $EXEL Upgraded at Zacks Investment Research https://t.co/NBnIC1NLQH August 10th 2019, 2:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.